367 related articles for article (PubMed ID: 17478498)
21. Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus.
Li Y; Lu Y; Polak U; Lin K; Shen J; Farmer J; Seyer L; Bhalla AD; Rozwadowska N; Lynch DR; Butler JS; Napierala M
Hum Mol Genet; 2015 Dec; 24(24):6932-43. PubMed ID: 26401053
[TBL] [Abstract][Full Text] [Related]
22. Evidence for chromosome fragility at the frataxin locus in Friedreich ataxia.
Kumari D; Hayward B; Nakamura AJ; Bonner WM; Usdin K
Mutat Res; 2015 Nov; 781():14-21. PubMed ID: 26379101
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Putative Epigenetic Regulatory Elements in the
Fernández-Frías I; Pérez-Luz S; Díaz-Nido J
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408537
[TBL] [Abstract][Full Text] [Related]
25. FXN methylation predicts expression and clinical outcome in Friedreich ataxia.
Evans-Galea MV; Carrodus N; Rowley SM; Corben LA; Tai G; Saffery R; Galati JC; Wong NC; Craig JM; Lynch DR; Regner SR; Brocht AF; Perlman SL; Bushara KO; Gomez CM; Wilmot GR; Li L; Varley E; Delatycki MB; Sarsero JP
Ann Neurol; 2012 Apr; 71(4):487-97. PubMed ID: 22522441
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
Vilema-Enríquez G; Quinlan R; Kilfeather P; Mazzone R; Saqlain S; Del Molino Del Barrio I; Donato A; Corda G; Li F; Vedadi M; Németh AH; Brennan PE; Wade-Martins R
J Biol Chem; 2020 Dec; 295(52):17973-17985. PubMed ID: 33028632
[TBL] [Abstract][Full Text] [Related]
27. Friedreich Ataxia: From the Eye of a Molecular Biologist.
Muthuswamy S; Agarwal S
Neurologist; 2015 Sep; 20(3):51-5. PubMed ID: 26375377
[TBL] [Abstract][Full Text] [Related]
28. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia.
Burnett R; Melander C; Puckett JW; Son LS; Wells RD; Dervan PB; Gottesfeld JM
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11497-502. PubMed ID: 16857735
[TBL] [Abstract][Full Text] [Related]
29. Small molecules affecting transcription in Friedreich ataxia.
Gottesfeld JM
Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
[TBL] [Abstract][Full Text] [Related]
30. FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia.
Chutake YK; Costello WN; Lam CC; Parikh AC; Hughes TT; Michalopulos MG; Pook MA; Bidichandani SI
PLoS One; 2015; 10(9):e0138437. PubMed ID: 26393353
[TBL] [Abstract][Full Text] [Related]
31. Frataxin gene point mutations in Italian Friedreich ataxia patients.
Gellera C; Castellotti B; Mariotti C; Mineri R; Seveso V; Didonato S; Taroni F
Neurogenetics; 2007 Nov; 8(4):289-99. PubMed ID: 17703324
[TBL] [Abstract][Full Text] [Related]
32. Animal and cellular models of Friedreich ataxia.
Perdomini M; Hick A; Puccio H; Pook MA
J Neurochem; 2013 Aug; 126 Suppl 1():65-79. PubMed ID: 23859342
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia.
Gottesfeld JM
Neurotherapeutics; 2019 Oct; 16(4):1032-1049. PubMed ID: 31317428
[TBL] [Abstract][Full Text] [Related]
34. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.
Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI
Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975
[TBL] [Abstract][Full Text] [Related]
36. Friedreich ataxia: an update on animal models, frataxin function and therapies.
González-Cabo P; Llorens JV; Palau F; Moltó MD
Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
[TBL] [Abstract][Full Text] [Related]
37. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure.
Bidichandani SI; Ashizawa T; Patel PI
Am J Hum Genet; 1998 Jan; 62(1):111-21. PubMed ID: 9443873
[TBL] [Abstract][Full Text] [Related]
38. Friedreich's ataxia--a case of aberrant transcription termination?
Butler JS; Napierala M
Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
[TBL] [Abstract][Full Text] [Related]
39. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.
Galea CA; Huq A; Lockhart PJ; Tai G; Corben LA; Yiu EM; Gurrin LC; Lynch DR; Gelbard S; Durr A; Pousset F; Parkinson M; Labrum R; Giunti P; Perlman SL; Delatycki MB; Evans-Galea MV
Ann Neurol; 2016 Mar; 79(3):485-95. PubMed ID: 26704351
[TBL] [Abstract][Full Text] [Related]
40. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
